Literature DB >> 11036138

Quality of life before and after laparoscopic fundoplication.

K Slim1, J Bousquet, F Kwiatkowski, G Lescure, D Pezet, J Chipponi.   

Abstract

BACKGROUND: Laparoscopic fundoplication is a well-established surgical option for the treatment of gastroesophageal reflux disease. The aim of this study was to assess the surgical outcomes from the patient's point of view by using a validated quality of life instrument.
METHODS: Fifty patients have been prospectively included. All patients underwent a standardized 270-degree posterior fundoplication. Quality of life was measured by the Gastrointestinal Quality of Life Index (GIQLI), a 36-item-questionnaire. The patients received the questionnaire before surgery, and 3 months and 1 year after surgery.
RESULTS: Preoperative score was 95.6+/-21 points. The score increased significantly (P <0.0005) at 3 months (103.6+/-16) and 1 year (111.4+/-22) after surgery. This improvement concerned the four domains of the questionnaire (symptoms, social functioning, physical status, and emotions). The score in patients at 1 year remained, however, significantly lower than that in healthy persons (126+/-18).
CONCLUSIONS: GIQLI is a sensitive tool to assess surgical outcomes after fundoplication. The quality of life after surgery did not reach the level of healthy population, not because of failure of surgery to treat GERD but probably because of functional dyspepsia that was present prior to surgery and did not change after fundoplication.

Entities:  

Mesh:

Year:  2000        PMID: 11036138     DOI: 10.1016/s0002-9610(00)00415-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist.

Authors:  J P Galmiche; F Zerbib
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome.

Authors:  T Kamolz; F A Granderath; R Pointner
Journal:  Surg Endosc       Date:  2004-12       Impact factor: 4.584

3.  Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

Authors:  Wei-Jei Lee; Po-Jui Yu; Weu Wang; Tai-Chi Chen; Po-Li Wei; Ming-Te Huang
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

Review 4.  The impact of gastroesophageal reflux disease on quality of life.

Authors:  T Kamolz; R Pointner; V Velanovich
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

5.  Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass.

Authors:  Wei-Jei Lee; Eng-Hong Pok; Abdullah Almulaifi; Ju Juin Tsou; Kong-Han Ser; Yi-Chih Lee
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

6.  Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus.

Authors:  Wei-Jei Lee; Ming-Hsien Lee; Po-Jui Yu; Jih-Hua Wei; Keong Chong; Shu-Chun Chen; Abdullah Almulaifi; Yi-Chih Lee
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

7.  Clinical results of laparoscopic fundoplication at ten years after surgery.

Authors:  B Dallemagne; J Weerts; S Markiewicz; J-M Dewandre; C Wahlen; B Monami; C Jehaes
Journal:  Surg Endosc       Date:  2005-12-07       Impact factor: 4.584

8.  Preoperative symptoms of irritable bowel syndrome predict poor outcome after laparoscopic cholecystectomy.

Authors:  Gareth Kirk; Ray Kennedy; Lloyd McKie; Thomas Diamond; Barry Clements
Journal:  Surg Endosc       Date:  2011-05-10       Impact factor: 4.584

9.  Laparoscopic antireflux surgery for the elderly: a surgical and quality-of-life study.

Authors:  Weu Wang; Ming-Te Huang; Po-Li Wei; Wei-Jei Lee
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

10.  Impairment of gastrointestinal quality of life in severely obese patients.

Authors:  Po-Jui Yu; Ju-Juin Tsou; Wei-Jei Lee; Kuo-Ting Lee; Yi-Chih Lee
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.